News Release

A new standard for reporting epidemic prediction research

“EPIFORGE” guidelines aim to improve quality, usefulness of epidemic forecasting manuscripts

Peer-Reviewed Publication

PLOS

A new standard for reporting epidemic prediction research

image: the medicine mask view more 

Credit: nastya_gepp, Pixabay, CCO (https://creativecommons.org/publicdomain/zero/1.0/)

An international panel has designed new guidelines to standardize how scientists report research that involves forecasting and prediction of how epidemics of infectious diseases unfold. Simon Pollett of the Walter Reed Army Institute of Research in Maryland, United States, and colleagues present the guidelines, called EPIFORGE, in the open-access journal PLOS Medicine on October 19th.

When reporting the results of certain kinds of medical research, such as clinical trials or systematic reviews of prior studies, researchers follow standardized checklists designed specifically for manuscripts published in those fields. Such guidelines are thought to improve the quality and usefulness of manuscripts; for instance, by making the research easier to understand, apply, or reproduce.

However, until now, no standard guidelines have existed for reporting epidemic forecasting and prediction research, despite the major impact of COVID-19 and other diseases for which epidemic predictions can have significant public health implications.

To meet this need, a six-person steering committee assembled several dozen panelists from around the world who either conduct epidemic prediction research themselves or apply predictions for public-health policy making and other uses. The panelists engaged in a Delphi process, in which they participated in several rounds of evaluating, removing, and adding proposed items to the final set of guidelines, which they call EPIFORGE.

The EPIFORGE checklist outlines 19 recommended items that manuscripts reporting epidemic predictions should include. For instance, one item calls for manuscripts to clearly outline the sources of any data that underlie their predictions. Another item calls for public availability of any computer code used to generate predictions.

The panelists hope that EPIFORGE will set new standards for reporting epidemic prediction research, thereby improving the quality and impact of such reports. The also invite feedback on the EPIFORGE guidelines from other researchers, policy makers, medical journal reviewers, and additional stakeholders.

“Infectious disease modeling is helping to guide the pandemic response,” coauthor Caitlin Rivers adds. “Right now, there are no clear standards for how results from models are reported. We brought together leaders from our field to define reporting standards so that models are better positioned to inform public health.”

 

#####

In your coverage please use this URL to provide access to the freely available paper in PLOS Medicine:

http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003793

Citation: Pollett S, Johansson MA, Reich NG, Brett-Major D, Del Valle SY, Venkatramanan S, et al. (2021) Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelines. PLoS Med 18(10): e1003793. https://doi.org/10.1371/journal.pmed.1003793

Author Countries: United States of America, Puerto Rico, United Kingdom, Spain, Thailand

Funding: We appreciate the role of the Outbreak Science and Model Implementation Working Group in developing this initiative, and the Johns Hopkins Center for Health Security for hosting the face-to-face consensus meeting and conducting the electronic Delphi process. We would also like to thank the MIDAS Coordination Center and the National Institutes of General Medical Sciences (NIGMS 1U24GM132013) for supporting travel to the face-to-face consensus meeting by members of the Working Group. NGR was supported by the National Institutes of General Medical Sciences (R35GM119582). Travel for SV was supported by the National Institutes of General Medical Sciences (1U24GM132013-01). BMA was supported by Bill & Melinda Gates through the Global Good Fund. RL was funded by a Royal Society Dorothy Hodgkin Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.